Tue, May 30, 2023

Gregory Renza Initiated (VRDN) at Buy and Held Target at $44 on, May 30th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-44-on-may-30th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Gregory Renza of RBC Capital, Initiated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $44 on, May 30th, 2023.

Gregory has made no other calls on VRDN in the last 4 months.



There are 8 other peers that have a rating on VRDN. Out of the 8 peers that are also analyzing VRDN, 0 agree with Gregory's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Gregory


  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Wednesday, May 10th, 2023
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $44 on, Wednesday, May 10th, 2023
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $48 on, Wednesday, May 10th, 2023
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $40 on, Wednesday, May 10th, 2023
  • Tiago Fauth of "Credit Suisse" Reiterated at Buy and Held Target at $51 on, Wednesday, May 10th, 2023
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $47 on, Monday, April 10th, 2023
  • Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $49 on, Thursday, March 30th, 2023
  • Michael Higgins of "Ladenburg Thalmann" Reiterated at Strong Buy and Held Target at $40 on, Thursday, March 9th, 2023